PRTT — Protect Pharmaceutical Income Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
- $12.64m
- $12.74m
Annual income statement for Protect Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.024 | 0.031 | 0.635 | 0.042 | 0.115 |
| Operating Profit | -0.024 | -0.031 | -0.635 | -0.042 | -0.115 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.024 | 0.458 | -0.635 | -0.042 | -0.123 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.024 | 0.458 | -0.635 | -0.042 | -0.123 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.024 | 0.458 | -0.635 | -0.042 | -0.123 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.024 | 0.458 | -0.635 | -0.042 | -0.123 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.537 | -0.571 | -0.068 | -0.038 | -0.11 |
| Dividends per Share |